ScholarWorks@Dongguk University

Journal of Enzyme Inhibition and Medicinal Chemistry  open-access icon

Journal Title

  • Journal of Enzyme Inhibition and Medicinal Chemistry

ISSN

  • E 1475-6374 | P 1475-6366

Publisher

  • Taylor & Francis

Listed on(Coverage)

JCR 2002-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
DOAJ 2018-2024
EMBASE 2016-2024

OA Info.

OA open-access icon

based on the information

  • 2018;2019;2020;2021;2022;2023;2024;2025;
Keywords enzymology, cell biology, chemical biology, microbiology, physiology, pharmacology
Review Process Anonymous peer review
Journal info. pages
Licences CC BY, CC BY-NC
Copyrights No
DOAJ Coverage
  • Added on Date : 2017-09-27T12:54:19Z
Subject(s) Medicine: Therapeutics. Pharmacology

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • ENGLAND

Aime & Scopes

  • Journal of Enzyme Inhibition and Medicinal Chemistry is an open access, international and interdisciplinary vehicle, publishing new knowledge and findings on enzyme inhibitors and inhibitory processes and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents and an understanding of their action. The Journal publishes research papers, short communications and reviews on current developments in enzymology, cell biology, chemical biology, microbiology, physiology, pharmacology leading to drug design, molecular recognition processes and distribution and metabolism of biologically active compounds. Among the various fields of study, special attention is given to structure and molecular aspects, enzyme kinetics and inactivation mechanisms, structure-activity relationships (QSAR, graphic techniques), drug development studies, drug release and control mechanisms in metabolic processes.

Homepage

Article List

1 - 7 out of 7 results.

SCIESCOPUS
Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studiesopen access

Farouk, Faten; Elmaaty, Ayman Abo; Elkamhawy, Ahmed; Tawfik, Haytham O.; Alnajjar, Radwan; Abourehab, Mohammed A. S.; Saleh, Mohamed A.; Eldehna, Wagdy M.; Al-Karmalawy, Ahmed A.

ArticleIssue Date2023CitationJournal of Enzyme Inhibition and Medicinal Chemistry, v.38, no.1, pp 1 - 16PublisherTAYLOR & FRANCIS LTD
SCIESCOPUS
Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell linesopen access

Son, Seohyun; Elkamhawy, Ahmed; Gul, Anam Rana; Al-Karmalawy, Ahmed A.; Alnajjar, Radwan; Abdeen, Ahmed; Ibrahim, Samah F.; Alshammari, Saud O.; Alshammari, Qamar A.; Choi, Won Jun, et al.

ArticleIssue Date2023CitationJournal of Enzyme Inhibition and Medicinal Chemistry, v.38, no.1, pp 1 - 17PublisherTAYLOR & FRANCIS LTD
SCIESCOPUS
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activityopen access

Mourad, Mai A. E.; Elmaaty, Ayman Abo; Zaki, Islam; Mourad, Ahmed A. E.; Hofni, Amal; Khodir, Ahmed E.; Aboubakr, Esam M.; Elkamhawy, Ahmed; Roh, Eun Joo; Al-Karmalawy, Ahmed A.

ArticleIssue Date2023CitationJournal of Enzyme Inhibition and Medicinal Chemistry, v.38, no.1, pp 1 - 20PublisherTAYLOR & FRANCIS LTD
SCIESCOPUS
Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducersopen access

El-Kalyoubi, Samar; Khalifa, Mohamed M.; Abo-Elfadl, Mahmoud T.; El-Sayed, Ahmed A.; Elkamhawy, Ahmed; Lee, Kyeong; Al-Karmalawy, Ahmed A.

ArticleIssue Date2023CitationJournal of Enzyme Inhibition and Medicinal Chemistry, v.38, no.1, pp 1 - 20PublisherTAYLOR & FRANCIS LTD
SCIESCOPUS
4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studiesopen access

Nada, Hossam; Elkamhawy, Ahmed; Abdellattif, Magda H.; Angeli, Andrea; Lee, Chang Hoon; Supuran, Claudiu T.; Lee, Kyeong

ArticleIssue Date2022CitationJournal of Enzyme Inhibition and Medicinal Chemistry, v.37, no.1, pp 994 - 1004PublisherTaylor & Francis
SCIESCOPUS
New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011-2021) focussing on structure-activity relationship (SAR) and docking insightsopen access

Elkamhawy, Ahmed; Ali, Eslam M. H.; Lee, Kyeong

ArticleIssue Date2021CitationJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, v.36, no.1, pp 1574 - 1602PublisherTAYLOR & FRANCIS LTD
SCIESCOPUS
Discovery ofN-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase Bopen access

Elkamhawy, Ahmed; Paik, Sora; Kim, Hyeon Jeong; Park, Jong-Hyun; Londhe, Ashwini M.; Lee, Kyeong; Pae, Ae Nim; Park, Ki Duk; Roh, Eun Joo

ArticleIssue Date2020CitationJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, v.35, no.1, pp 1568 - 1580PublisherTAYLOR & FRANCIS LTD
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114

Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어